Laure P.
- Country
- France
- Department
- Medical Oncology
Research Overview
- Phase II Evaluation of De-escalated Therapy with Etoposide, Cisplatin, and Carboplatin in Stage IIa/IIb Seminoma Less Than 3 cm
- Prospective Evaluation of Personalized Treatment Efficacy and Safety in Young Adults with Poor-Prognosis Non-Seminomatous Germ-Cell Tumors Using Early Tumor Marker Kinetics
- Thromboprophylaxis in good and intermediate prognosis advanced germ cell tumors (GIG-T)
Data & Insights
Has run more than one trial at 19 of 36 partner sites.
Specializations
Germ Cell Tumor Management
The investigator specializes in treating various forms of germ cell tumors, with particular emphasis on seminomas and non-seminomatous germ cell tumors (NSGCT). Their research encompasses both early-stage and advanced disease management.
- Stage IIa/IIb seminoma treatment optimization
- Poor-prognosis NSGCT therapeutic approaches
- Advanced germ cell tumor management
Their work includes investigating therapeutic de-escalation strategies and personalized treatment approaches.
Oncological Complications
The investigator focuses on managing and preventing complications in cancer patients, particularly those undergoing cisplatin-based chemotherapy. Their research addresses critical supportive care aspects in oncology.
- Thromboprophylaxis in metastatic disease
- Venous thromboembolic event prevention
- Risk factor assessment in cancer patients
Their work emphasizes preventive strategies for high-risk oncology patients.
Biomarker Research
The investigator studies the role of various biological markers in cancer assessment and treatment monitoring, including innovative approaches to disease evaluation.
- miRNA M371 marker evaluation
- Tumor marker kinetics assessment
- Treatment response monitoring
Their research integrates biomarker analysis with therapeutic decision-making.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.